Podcasts about opioids

Grow your management tools for opioid withdrawal in the hospital. Investigate how to decide between methadone and buprenorphine, additional medications to manage symptoms and how and when to use short-acting opioids for management of withdrawal. We're joined by Ashish Thakrar, MD at the University of Pennsylvania.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Symptoms of opioid withdrawal Medications for the management of opioid withdrawal Buprenorphine precipitated withdrawal Starting Buprenorphine: Experiences and Strategies  Titrating Methadone: Dosage and Adjuncts Adjunctive short-acting opioids Emerging Trends in Drug Supply: Xylazine and Medetomidine Outro  Credits Producer, Show Notes: Zina Huxley-Reicher Infographics: Zina Huxley-Reicher MD and Zoya Surani Hosts: Carolyn Chan, MD MHS, Zina Huxley-Reicher MD, Shawn Cohen, MD Reviewer: Payel Jhoom Roy, MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Ashish Thakrar, MD MHSP Sponsor: Mint Mobile  Shop plans at MINTMOBILE.com/CURB Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe! Sponsor: FIGS  We've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.

About this episode: This July, a dangerous influx of opioids triggered two mass overdose events in the Penn North neighborhood of Baltimore. A swift and nimble response from the city and community stakeholders resulted in zero fatalities. In this episode: Dr. Letitia Dzirasa and Sara Whaley from the City of Baltimore explain what happened, detail the multipronged emergency response, and share how the city plans to move forward in addressing the opioid crisis. Guest: Dr. Letitia Dzirasa is the Deputy Mayor of Health and Human Services with the City of Baltimore. Sara Whaley, MPH, MSW, is the executive director of the City of Baltimore's Overdose Response Team. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Overdose Response Strategic Plan—City of Baltimore Community leaders, experts address Baltimore's overdose crisis—WEAA Baltimore mass overdose: 'Coordinated neighborhood stabilization response' launched in Penn-North—WBAL Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Mississippi has been received tens of millions of dollars in opioid settlements each year since 2022, and the use of those dollars has been mostly a mystery. But a Mississippi Today investigation this summer found that of over $124 million the state has received, less than $1 million has been used by public officials to address addiction. Managing editor Kate Royals and mental health reporter Allen Siegler speak with Tricia Christensen, a nationally recognized leader in overdose prevention and opioid settlement spending from Tennessee, about how this compares to other states and what it means for Mississippians harmed by the overdose epidemic.   

When a company's values don't match its actions, the impact can be devastating. Kim and Amy speak with investigative journalist Gardiner Harris about his book, No More Tears: The Dark Secrets of Johnson & Johnson. Harris uncovers how a company once seen as the gold standard of integrity used its famous “Credo” to build emotional trust while covering up harmful practices—from baby powder linked to cancer to its role in the opioid crisis. The conversation goes beyond one company, raising bigger questions about accountability, transparency, and the systems meant to keep us safe. It's a candid look at how misplaced trust can cause lasting damage—and what it really takes to create a culture where honesty and responsibility come first. Get all of the show notes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠RadicalCandor.com/podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Episode Links:⁠⁠⁠⁠⁠⁠⁠⁠⁠ Gardiner Harris No More Tears: The Dark Secrets of Johnson & Johnson  The Weekly | A Secret Opioid Memo That Could Have Slowed an Epidemic | The New York Times A Devastating New Exposé of Johnson & Johnson Indicts an Entire System | The New Republic The Johnson & Johnson Cancer Drug Scandal That Encapsulates Corruption In Health Care | STAT News J&J Is Back On The Legal Warpath After Striking Out In Baby Powder Bankruptcy | Reuters Antipsychotic Drugs and Nursing Home Residents: What Do the Different Numbers Mean? | Center for Medicare Advocacy Empire of Pain: The Secret History of the Sackler Dynasty The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth  Physician Payments Sunshine Act (also known as the Open Payments program) Watch Cold Case: The Tylenol Murders | Netflix  Connect: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bluesky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Introduction Kim and Amy introduce Gardiner Harris, investigative journalist and author. (00:01:01) No More Tears Why Gardiner's book hasn't been widely covered by the media. (00:07:35) Hidden Dangers of Products Overview of Johnson & Johnson's vast range of dangerous products. (00:15:13) Antipsychotics in Nursing Homes How antipsychotics were pushed to sedate elderly patients. (00:16:58) Opioids & Corporate Responsibility The role Johnson & Johnson played in the opioid epidemic. (00:24:04) The Power of Branding & Emotional Trust The exploitation of emotional branding to avoid accountability. (00:27:28) Incentives, Conflicts, & Complicity How financial incentives corrupted doctors, researchers, and hospitals (00:39:12) Breaking Points & Speaking Up Stories about the individuals affected by Johnson & Johnson. (00:47:27) The Cult of the Credo How J&J weaponized its corporate credo to silence whistleblowers. (00:52:19) How J&J Got Away With It The ways J&J avoided accountability and hid decades of misconduct. (00:57:36) Tylenol, Safety, & the Illusion of Trust The FDA's inability—or unwillingness—to enforce safety despite evidence. (01:03:29) Hope, Oversight & Individual Action How individual action and awareness can drive systemic change. (01:08:10) Conclusion Learn more about your ad choices. Visit megaphone.fm/adchoices

Dan Buck talks with country western singer Mary Kutter about her song The Devil Wore a Lab Coat, a bold take on the opioid epidemic and the pharmaceutical industry's role in devastating small-town America. Kutter opens up about how Big Pharma targeted vulnerable communities, the kickbacks given to doctors, and the widespread addiction that followed.

While doctors are prescribing fewer and fewer opioids, there's one that's not going away – buprenorphine, often known by its brand name of Suboxone. Compared to other narcotics, it's harder to abuse. It's far less dangerous than the synthetic street drugs. And it reduces the risk of overdosing. But it's still an opioid that is very hard to get off of. The number of Tennesseans prescribed these opioids as addiction treatment jumped by 40% in just five years. As we look this week at all sides of a philosophy known as “harm reduction,” today we focus on access to the opioids meant to get us out of the opioid crisis.GuestsLeslie Cole, MD, addiction physician, Springfield, Tenn.Josh Draper, program manager, Sumner Prevention CoalitionTracy Frame, PharmD, professor of pharmacy practice and director of the Flourish Mobile Clinic, Belmont UniversityChap Cuthbert, community response peer support, Mental Health Cooperative

A deep look at suicide prevention with Essentia's Dr. Kohlhase, a preview of Fargo's Drekkerfest 11, and Prairie Beat on opioids and the life-saving role of Narcan.

American's are dying by overdose in record numbers, victims of the worst opioid addiction epidemic in history. In Mobile, Alabama two doctors are serving up heavy doses of the dangerous drugs. One drug the doctors prescribe is 50 times more potent than heroin and the multi-billion dollar drug company that makes it is paying them to push it. While both the drug maker and these doctors are unrelenting in turning patients' pain into enormous profits, some families of those who die hold the doctors responsible. (Original television broadcast: 3/5/2018) Want to binge watch your Greed? Full episodes and the latest news at: https://www.cnbc.com/american-greed/

Health Affairs' Rob Lott interviews Nora Volkow, director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, to discuss addiction as a brain disorder, treatments for opioid use disorder, and what's next in addiction research. Order the September 2025 issue of Health Affairs, which focuses on insights on the opioid crisis.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

Paul Howe, COO of Protega Pharmaceuticals, is focused on how abuse-deterrent technology can address the opioid crisis and the need for mandates for insurance coverage of safer abuse-deterrent formulations. The SentryBond technology was specifically designed for immediate-release opioids to make it difficult to manipulate pills for abuse via crushing, inhaling, or injecting. Protega partnered with software company Opus to offer a program that helps educate chronic pain patients, manage their treatment, and provides physicians with risk stratification data to improve care and reduce the likelihood of abuse. Paul explains, "Most importantly from our standpoint is to protect from the risk of misuse, abuse, and diversion, which is escalation from orally taking medications to crushing, inhaling, injecting, or smoking. Unfortunately, when that escalation happens, many times patients end up on illicit fentanyl and heroin through the black market. So what we're trying to do is stop that escalation through our abuse deterrent technology and our medication. It's called SentryBond abuse deterrent technology, the company's Protega Pharmaceuticals."   "We also have a software program that we're now offering to physicians that deal and work with a lot of patients with chronic pain that really helps patients with chronic pain understand how to treat their pain and also titrate down off medications when possible, or at least get on the lowest possible dose and try multimodal care, try other types of avenues of procedures, different things they can do to help with their chronic pain." #ProtegaPharmaceuticals #PainManagement #ChronicPain #OpioidAbuse #OpioidPolicy #AbuseDeterrent. protegapharma.com Listen to the podcast here

Paul Howe, COO of Protega Pharmaceuticals, is focused on how abuse-deterrent technology can address the opioid crisis and the need for mandates for insurance coverage of safer abuse-deterrent formulations. The SentryBond technology was specifically designed for immediate-release opioids to make it difficult to manipulate pills for abuse via crushing, inhaling, or injecting. Protega partnered with software company Opus to offer a program that helps educate chronic pain patients, manage their treatment, and provides physicians with risk stratification data to improve care and reduce the likelihood of abuse. Paul explains, "Most importantly from our standpoint is to protect from the risk of misuse, abuse, and diversion, which is escalation from orally taking medications to crushing, inhaling, injecting, or smoking. Unfortunately, when that escalation happens, many times patients end up on illicit fentanyl and heroin through the black market. So what we're trying to do is stop that escalation through our abuse deterrent technology and our medication. It's called SentryBond abuse deterrent technology, the company's Protega Pharmaceuticals."   "We also have a software program that we're now offering to physicians that deal and work with a lot of patients with chronic pain that really helps patients with chronic pain understand how to treat their pain and also titrate down off medications when possible, or at least get on the lowest possible dose and try multimodal care, try other types of avenues of procedures, different things they can do to help with their chronic pain." #ProtegaPharmaceuticals #PainManagement #ChronicPain #OpioidAbuse #OpioidPolicy #AbuseDeterrent. protegapharma.com Download the transcript here

9/8/25: Farmer's Almanac editor Carol Connare on winter weather predictions. Megan Zinn w/ local sci-fi & fantasy author Elizabeth Bear on "The Folded Sky" & "Angel Maker." Holyoke Mayor Josh Garcia: storm damage, opioid settlement funds, & the 9/16 Preliminary. Prof Amilcar Shabazz & Tom Weiner: the threat to Black Studies in US, & Dr. Johnnetta Cole's talk on what to do about it.

Send us a textNavy veteran Saja Ramos shares her powerful journey from military service to addiction recovery, now serving as VP of Military and Veteran Affairs at American Addiction Centers. After a traumatic brain injury and vision loss from a car accident in Italy, she transformed her personal struggle with opioid addiction into a mission helping other veterans find treatment and purpose.• Joined the Navy in 2008 after high school, working in Information Technology in Sicily, Italy• Suffered a car accident resulting in TBI, PTSD, and vision loss in her right eye• Medically transitioned from service in 2011, leading to struggles with opioid addiction• Completed four months in residential treatment and nine months in sober living• Earned degrees in interdisciplinary studies and social work using her GI Bill• Now helps veterans access addiction treatment at American Addiction Centers• Works with clinical teams to ensure veterans receive appropriate, specialized care• Advocates for better veteran screening and assessment in healthcare settings• Challenges the stigma around veteran identity, especially for women and non-combat veterans• Practices "recovering out loud" to inspire others on their journey to healingFor veterans seeking help with addiction or substance use disorders, call American Addiction Centers at 866-288-1836 or reach Saja directly at 908-239-6417.

LightSpeed VT: https://www.lightspeedvt.com/ Dropping Bombs Podcast: https://www.droppingbombs.com/ What if the natural cure you've been searching for has been buried under decades of propaganda and misinformation? In this episode of Dropping Bombs, I sit down with William O'Boyle – former college athlete, recovered addict, and founder of Meda Leaf Farms – to unpack the truth about CBD, CBG, hemp, and how these natural compounds are transforming lives. With RFK championing plant-based healing, they explore why hemp could be the key to real wellness.   William shares his powerful story of battling opioid addiction, overcoming a near-death experience, and how one gummy opened the door to a new life. Brad and William dive into CBD benefits for sleep, anxiety, ADHD, CTE, and pain relief, plus why the endocannabinoid system is one of the most overlooked parts of your health. They also expose the history of hemp criminalization, the industries that killed it, and why it's time to reclaim your health using plant-based medicine.  

This week on the Conduit Street Podcast, Michael Sanderson and Policy Associate Sarah Sample sit down with Anne Arundel Deputy County Attorney Hamilton Tyler to unpack a local case now headed to the Maryland Supreme Court on September 9. At the center of the case: whether counties can bring public nuisance claims tied to the staggering costs of the opioid crisis.How did this case start? What does it mean for local governments footing the bill for abatement and recovery? And why is the state's highest court taking it up now? Tune in for a behind-the-scenes look at the legal journey, what's at stake for counties, and how the outcome could shape the way governments confront public health crises in the future.Follow us on Socials!MACo on TwitterMACo on Facebook

Picture this, a powerful synthetic opioid that quietly morphs into one of the nation's most lethal drug crises. A drug that can be slipped undetected into heroin, counterfeit pills...the nation's bloodstream. You've seen and may have even been touched by the devastating impact of fentanyl. And now, a different class of ultrapotent synthetic opioids called nitazenes are following an eerily familiar path. Just how dangerous are these drugs and where are they coming from? Dr. Gregory McDonald, chair of the Department of Forensic Medicine and Pathology at the Philadelphia College of Osteopathic Medicine, joins USA TODAY's The Excerpt to unpack those questions and more.Please let us know what you think of this episode by sending a note to podcasts@usatoday.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Health Affairs' Rob Lott interviews Brendan Saloner of Brown University about his recent paper exploring how scaling up opioid treatment and harm reduction programs could reach more people. Order the September 2025 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

The use of a newer class of opioids, nitazenes, is growing across the US. Once rarely seen in illicit markets before 2019, the drugs have been found on nearly every continent at this point. Their elevated potency—250 to 900 times stronger than morphine for the most common nitazene—makes them far deadlier than heroin and fentanyl. Can we slow or stop the use of these opioids before they do more damage?

"Literally with one prescription, it hijacked Christopher's brain and the addiction started." - Cammie Wolf Rice   Cammie Wolf Rice is the founder of the CWC Alliance, an initiative developed in response to the tragic loss of her son, Christopher, to opioid misuse. Her career is marked by a dedicated transformation of personal grief into a powerful healthcare campaign aiming to rectify systemic gaps in pain management and substance use prevention. Rice spearheaded the development of the Life Care Specialist (LCS) role in healthcare, a pioneering position designed to ensure comprehensive, trauma-informed care. Her efforts have been recognized as subjects of studies at Harvard Business School and endorsed in Georgia's House Study Committee on opioid alternatives.   Episode Summary: In this emotionally powerful episode of "Oh, My Health... There is Hope!" host Jana Short sits down with Cammie Wolf Rice, a remarkable advocate for opioid misuse awareness and prevention. The episode unveils Cammie's poignant journey following the unfortunate death of her son, Christopher, due to opioid addiction. Fueled by personal tragedy, Cammie established the CWC Alliance and introduced the Life Care Specialist role within healthcare settings to bridge crucial gaps in patient care, emphasizing trauma-informed pain management.   Throughout the conversation, key themes of addiction awareness, healthcare improvements, and alternative pain management come to the fore. Cammie speaks candidly about the moments that shaped her advocacy, detailing the challenges and breakthroughs in her mission. Central to the discussion is her written work, "The Flight My Opioid Journey," which offers support and resources to those affected by similar stories. The episode is a compelling reminder of the opioid crisis's impact on families while highlighting Cammie's persistent drive to ensure no other parent experiences the same loss.   Key Takeaways: Turning Tragedy into Purpose: Cammie Wolf Rice channels her grief over losing her son into proactive efforts to address opioid misuse, creating impactful change in healthcare systems. Introduction of the Life Care Specialist Role: This pioneering role in hospitals serves as a patient advocate, ensuring trauma-informed care and supporting patients with non-addictive pain management strategies. Educational Initiatives: Cammie's book and app recommendations aim to raise awareness and provide resources for substance misuse prevention, encouraging informed decision-making. Wider Societal Stigma: The discussion highlights the importance of overcoming the stigma associated with addiction to foster an environment of understanding and proactive care. Expanding Impact: The continuation of efforts to include life care specialists in more hospitals, backed by opioid settlement funds, showcases the ongoing work to improve healthcare responses to addiction.   Resources: Website: https://cwc.ngo/ https://cammiewolfrice.com/ LinkedIn: https://www.linkedin.com/in/cammierice/ IG: https://www.instagram.com/cwcalliance ‌   Get a free subscription to the Best Holistic Life Magazine, one of the fastest-growing independent magazines centered around holistic living: https://bestholisticlife.info/BestHolisticLifeMagazine. Get in touch with Jana and listen to more podcasts: https://www.janashort.com/ Show Music ‘Hold On' by Amy Gerhartz: https://www.amygerhartz.com/music. Grab your FREE gift today: https://bestholisticlife.info/BestHolisticLifeMagazine Connect with Jana Short: https://www.janashort.com/contact/

On this episode of the VinnyRoc Podcast, Vincent Vargas sits down with John Ramsey, Senior R&D Manager at Diversified Botanics, to dive into a powerful conversation about natural medicine, CBD, kratom, and the dangers of 7-hydroxy mitragynine (7-OH). John, a veteran and former Army medic, shares his journey from the military to the hemp and CBD industry, explaining how natural remedies like CBD and kratom helped him avoid the destructive cycle of pharmaceutical painkillers. Together, Vince and John explore: The truth about CBD isolate and why it became a breakthrough in non-psychoactive relief. How the endocannabinoid system works and why our bodies are designed to receive cannabinoids. What kratom really is, its traditional uses, and how it differs from synthetic and dangerous 7-hydroxy extracts. The opioid epidemic in the military and how kratom may help support recovery. Why Diversified Botanics is fighting to eliminate 7-OH and create safe, transparent, third-party tested products. This episode is about cutting through the noise, misinformation, and stigma to give you a clearer picture of CBD, kratom, and the fight to keep natural remedies safe. If you want to support the petition to regulate and restrict 7-hydroxy, check the link here: https://www.change.org/p/protect-our-heroes-stop-the-deception-destroying-lives

Madison Hluchan, ASTHO Assistant Director of Medicaid Health Systems Partnerships, details how a new ASTHO resource can help your team with the Rural Health Transformation Program; and JoAnne Deehr, ASTHO Senior Analyst for State Health Policy, shares prevention and response policies to reduce overdoses involving synthetic opioids. ASTHO Blog Article: Understanding and Applying for the Rural Health Transformation Program ASTHO Blog Article: Prevention and Response Policies to Reduce Overdoses Involving Synthetic Opioids ASTHO Web Page: Legislative Alerts  

We're joined by Dr. Karl Benzio, Chief Psychiatric Officer at Honey Lake Clinic and Medical Director at the American Association of Christian Counselors. With his decades of experience in psychiatry and addiction treatment, Dr. Benzio is raising the alarm on a growing problem, the explosion of sports betting in America. As states rush to legalize and profit from gambling, he warns this may turn into the next opioid-level crisis, leaving families shattered and lives destroyed. Dr. Benzio will break down why the addictive pull of sports betting is so dangerous, what patterns he's already seeing, and how America must respond before it spirals out of control.

The opioid epidemic continues to devastate communities across Maryland, and Baltimore City remains at the forefront of both the crisis and the response. In this episode, Karrington Anderson from the MACo policy team sits down with Baltimore City Councilwoman Phylicia Porter to discuss the city's evolving strategies for confronting opioid misuse, saving lives, and investing in long-term recovery.Councilwoman Porter shares how her lived experience and legislative leadership shape her work, the city's preliminary Overdose Response Strategic Plan, and the critical role of equity in harm reduction. From settlement funds and access to treatment to housing, workforce support, and stigma reduction, this conversation explores how Baltimore is working to turn immediate responses into lasting change—while providing lessons for counties and communities statewide.Follow us on Socials!MACo on TwitterMACo on Facebook

Host Dr. Shawn McNeil is joined by Dr. Robert Sherrick to discuss his new article Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs featured in the July/August issue of the Journal of Addiction Medicine.   Robert Sherrick, MD, DFASAM, is chief science officer for Community Medical Services, a company that serves patients through over 70 Opioid Treatment Programs in 12 states. He also has experience working at an inpatient addiction treatment facility, Pathways Treatment Center, treating all forms of substance use disorders and dual diagnosis patients.   Dr. Sherrick has been providing medication treatment for opioid use disorder since 2003, initially in an office setting using buprenorphine and subsequently with methadone in Opioid Treatment Programs. He established a state-wide buprenorphine treatment program for VA Montana with extensive use of telemedicine. He is board certified in internal medicine and addiction medicine through the American Board of Preventive Medicine. He is past president of the Northwest Chapter of the American Society of Addiction Medicine (ASAM). - Article: Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs

Welcome (back) to the Opioidology podcast series! Next up to bat, ‘Opioid Selection”. What's YOUR “Go To Opioid”??? No really, pick a given patient scenario, as respectively there's many, and what is your “Go To Opioid” when a prescription opioid is warranted??? Pain Guy posed this question on LinkedIn over a year ago, and society failed (as in succumbed to the Opioidphobia culture). So join us in this episode to take a methodical journey distinguishing prescription opioids to once and for (almost) all, be able to have our ducks in a row for opioid selection. Listen in to this Pain Pod episode for an unbiased, in your face, here's how it is approach to explaining opioid selection (beyond the “To Opioid or Not to Opioid” debate). Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

In this episode of The Church Planting Podcast, host Greg Nettle welcomes Mark DeYmaz, founding pastor of Mosaic Church in Little Rock and a leading voice in the multiethnic church movement. Mark pulls back the curtain on how his church is thriving through missional vitality and church economics—generating revenue, leveraging real estate, serving the poor, and reaching their community with tangible expressions of the Gospel. Topics include: The three-legged church model (spiritual, social, financial). How Mosaic transformed a Kmart into a 100,000 sq. ft. center of ministry and enterprise. Why your church needs a nonprofit arm to access grants (including $80B in opioid funds available through 2038). The importance of long obedience in the same direction. Real stories of hope—including a homeless community preaching courage back to Mark. Helpful resources: Mosaix Network — conferences, coaching, and content Mark's books on Amazon Midtown Event Center – Mosaic's multi-use space This is a masterclass in leadership, sustainability, and Gospel innovation. A must-listen for every church leader looking to thrive in the 21st century. 01:00 - Mark's upcoming book on the Prayer of St. Francis 02:45 - Overview of Mosaic Church's mission and context 04:00 - Economic challenges of inner-city churches 06:00 - Transforming a former Kmart into a ministry hub 08:00 - “That is the church” — redefining what church looks like 09:00 - How to get started: shifting your mindset 10:00 - The 3-legged church model: spiritual, social, financial 12:00 - Creating a nonprofit to apply for grants 14:00 - Rethinking biblical stewardship 15:30 - Grants, real estate, and income strategies 17:00 - Opioid nexus grant: $80B available through 2038 18:30 - Mosaix Network and national conference 20:00 - Why it's the premier multiethnic church conference 21:00 - What excites Mark most about the future of church 22:00 - Matthew 5:16 and the power of visible good works 23:30 - Why sustainability takes 7–10 years (or more) 24:30 - Faith and tears: a homeless community encourages Mark 26:30 - Final thoughts and encouragement for church planters

Cleveland's latest argument in court against the Browns move seems desperate. Why make it when it has other arguments that are much stronger? Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome (back) to the Opioidology podcast series! Next up to bat, ‘Opioid Selection”. What's YOUR “Go To Opioid”??? No really, pick a given patient scenario, as respectively there's many, and what is your “Go To Opioid” when a prescription opioid is warranted??? Pain Guy posed this question on LinkedIn over a year ago, and society failed (as in succumbed to the Opioidphobia culture). So join us in this episode to take a methodical journey distinguishing prescription opioids to once and for (almost) all, be able to have our ducks in a row for opioid selection. Listen in to this Pain Pod episode for an unbiased, in your face, here's how it is approach to explaining opioid selection (beyond the “To Opioid or Not to Opioid” debate). Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

Dr. Chad Kollas has spent more than two decades challenging myths and misinformation about opioids in pain care. In this episode, he joins us to break down the FDA's latest opioid label changes, explain why they matter for patients, and share his perspective as a palliative care physician who has been on the frontlines of this debate since the early 2000s.We talk about:The significance of the FDA's new opioid labelThe ethical failures of randomized controlled trials (RCTs) in pain patientsHow propaganda has shaped the narrative around opioidsWhat patients and providers need to know moving forwardIf you've ever wondered how we got here and what hope there is for change you won't want to miss this conversation.Dr. Chad Kollas' study: https://pmc.ncbi.nlm.nih.gov/articles/PMC10790545/

Opioids are powerful drugs that can help people who are struggling with pain from severe injuries or illness, but the compounds are also highly addictive and the CDC says overdose is one of the leading causes of injury death for adults in the U.S. with rates quickly climbing from the early 2000s. In recent years, overdose deaths have declined in most of the country but remain high in Alaska. Why are rates still elevated here and what is being done to help people stay safe from illicit drugs? We discuss it on this Talk of Alaska.

Hometown Radio 08/26/25 3p: Guest Host Jeanette Trumpeter talks with Kim Lacey - CEO and Founder of SLO Overdose Awareness Day Jenn Rhodes-County of San Luis Obispo Behavioral Health Opioid Safety Coordinator

8/25/25: Atty Joel Feldman: rent stabilization now! Megan Zinn w/ Jill Bialosky: "The End is the Beginning,” remembering her mom. Prof Amilcar Shabazz w/ artist Kay Douglas: "Antebellum" at Ctr for Peace through Culture. Amherst Town Mgr. Paul Bockelman & Health Dir Kiko Malin: opioids settlement funds & potholes.

New details emerge on an alleged terror plot near Quebec City. One of those charged spoke openly about another Waco massacre. Four men — including two serving soldiers — are accused of hoarding a massive cache of weapons to supply an anti-government militia and a plot that included violence against government authorities.Also: Opioid deaths in Canada were down last year. The reasons are varied, including cleaner drugs, and how people are taking them. But also — many people had already died, due to fentanyl poisoning.And: A human case of Rocky Mountain spotted fever has been reported in Canada.The tick-borne disease, which can be deadly if not treated early, is more common in the U.S. Climate change is changing tick migration patterns.Plus: Saskatchewan premier Scott Moe heading to China to talk canola, Israel intensifies mission in Gaza City, and more.

Our favorite feisty former Mayor of Hagerstown Emily Keller updates Nestor on her evolving role as the Special Secretary of Opioid Response under the Wes Moore administration and the role of Naloxone in saving lives during an overdose crisis. The post Former Hagerstown Mayor Emily Keller updates Nestor on Maryland Opioid Response assignment at MACo first appeared on Baltimore Positive WNST.

As local governments across the country receive opioid settlement money, a new crowdsourced database is tracking instances of alleged misuse.

Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care

Interview with Anna D. Ratzliff, MD, PhD and Andrew J. Saxon, MD authors of Collaborative Care for Opioid Use Disorder in Primary Care: A Hybrid Type 2 Cluster Randomized Trial. Hosted by John Torous, MD. Related Content: Collaborative Care for Opioid Use Disorder in Primary Care

The opioid crisis was declared a public health emergency in 2017 — and it's only grown since. Even followers of Christ aren't immune. On the next Equipped, Dr. Holly Geyer from the Mayo Clinic joins guest host Susie Larson. Dr. Geyer has seen first-hand the heartbreak of addiction and offers both medical insight and hope in Christ. If you or someone you love is struggling, this conversation could be a lifeline. Featured resource:Ending the Crisis: Mayo Clinic’s Guide to Opioid Addiction and Safe Opioid Use by Holly L. Geyer, M.D. August thank you gift:The Quiet Time Kickstart by Rachel Jones Equipped with Chris Brooks is made possible through your support. To donate now, click here.

Association between housing status and mental health and substance use severity among individuals with opioid use disorder and co-occurring depression and/or PTSD  BMC Primary Care  This is a cross-sectional analysis of associations between housing status and mental health and substance use severity among primary care patients with co-occurring disorders. The study is a sub-analysis using data from the Collaboration Leading to Addiction Treatment and Recovery from other Stresses randomized controlled trial, which tested the Collaborative Care Model for primary care patients with OUD and co-occurring depression and/or PTSD. Of 797 patients in the study, 13% were currently unhoused, 24% were unstably housed, and 63% were stably housed. Those who were unhoused were on average younger and had not used prescribed MOUD in the past 30 days. The analysis found that being unhoused or unstably housed was significantly associated with higher PTSD symptom severity, depression symptom severity, opioid use severity, and opioid overdose risk behaviors compared to those who were stably housed.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Opioid misuse and overdoses are a serious public health crisis across Washington state and nationwide. From 2019 to 2021, the annual number of opioid drug overdose deaths in the state nearly doubled. About 55 people in America die each day from an overdose of prescribed or illicit opioids, including fentanyl and heroin.It's crucial to get real information and education on opioid use to communities. Washington State University faculty and staff, including assistant professor Nicole Rodin at the College of Pharmacy and Pharmaceutical Sciences, have teamed up with colleagues across Washington to get accurate and useful facts out to people and try to prevent overdoses. They've focused on rural communities hit hard by opioid use, often with limited medical facilities and support.Rodin talks with Washington State Magazine editor Larry Clark about the scope of the opioid epidemic, effective education, reducing stigma, and how we can all lend our support.There's a need to treat substance use disorders as health care, Rodin says. “It is a disorder. It is a medical condition, and we have yet to treat it that way as a society.”Read more about WSU efforts on curbing substance use and addiction in the Spring 2024 issue of Washington State Magazine.Other resources:Rural Opioid Technical Assistance Collaborative (Northwest Region 10)Opioid Overdose Prevention, Recognition, and Response (Washington State Department of Health)How to talk about substance use (Washington State Magazine, Spring 2024)WSU PEAR—Program of Excellence in Addictions ResearchWSU APPL—Analytics and PsychoPharmacology LaboratorySupport the show______________________________________________________________________________Want more great WSU stories? Follow Washington State Magazine: LinkedIn @Washington-State-Magazine Bluesky @wastatemagazine.bsky.social X (formerly Twitter) @wsmagazine Facebook @WashingtonStateMagazine Instagram @WashingtonStateMagazine YouTube @WashingtonStateMagazine Email newsletter How do you like the magazine podcast? What WSU stories do you want to hear? Let us know. Give to the magazine

Dr Pat Murphy on his holistic approach to addiction treatment. James P. Murphy, MD, DFASAM is founder and CEO of Murphy Pain Center. He serves gratis as an Assistant Clinical Professor at the University of Louisville School of Medicine. He has earned a Master of Medical Management from the University of Southern California's Marshall School of Business. He has board certifications in Pain Medicine, Addiction Medicine, and Anesthesiology. His Pain Management fellowship was at Rochester, Minnesota's Mayo Clinic, where he also served on the faculty of the Mayo Medical School.

In this week's cannabis news episode of High on Home Grown: Macky covers a new UK poll showing that 80% of NHS doctors would prescribe medical cannabis, plus news that half of Guernsey's deputies back cannabis decriminalisation. Margaret looks at the growing conservative push against legal cannabis and a new study finding that U.S. teens often fail to complete rehabilitation for cannabis use disorder. John discusses a major study showing medical marijuana significantly reduces opioid use among chronic pain patients, and breaks down Trump's federal policy on marijuana reclassification, what it would mean, and what the data shows. Come and join in the discussion about any of these news articles on our cannabis growing forum, Discord server, or any of your favourite social networks. Visit our website for links.

An innovative approach to combat opioid overdoses on the city's North Side full 30 Sat, 16 Aug 2025 05:35:23 +0000 rKmxZNzppvmKEkFePdLygOzHVIIn7iHY news Chicago All Local news An innovative approach to combat opioid overdoses on the city's North Side A dive into the top headlines in Chicago, delivering the news you need in 10 minutes or less multiple times a day from WBBM Newsradio. 2024 © 2021 Audacy, Inc. News False https://player.amp

The Trump administration is trying to restrict access to a substance you might find at your local smoke shop. The FDA in late July announced plans to crack down on 7-OH. Commissioner Marty Makary described it as an opioid that can be more potent than morphine and the agency's pushing to get it classified as a Schedule 1 substance -- like ecstasy or heroin. You may not have heard of 7-OH, but you’ve probably heard of kratom. It’s the substance that 7-OH comes from – and it’s controversial in its own right. Some states have banned kratom. The federal government tried to classify it as a Schedule 1 substance in 2016 but opted not to after getting a wave of pushback. This year Washington state regulators withdrew a proposal to designate kratom as a Schedule 1 substance, saying it didn’t meet the criteria. So for now, you can buy kratom products in the state. We wanted to know more about both kratom and 7-OH, so we checked in with a research professor at the University of Washington for insight. Guest: Caleb Banta-Green, research professor at the University of Washington and director of the Center for Community-Engaged Drug Education, Epidemiology and Research. Related stories: FDA recommends concentrated Kratom be scheduled as illicit substance | The Hill What to know about changes to kratom sold in Seattle | Axios Seattle Kratom & 7-OH: What do we know about use, safety, and overdose risk? | Addictions, Drug & Alcohol Institute (University of Washington) What is 7-OH? Opioid-like product may get banned by FDA | USA TODAY Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes. Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Ed Bisch is an activist who founded Relatives Against Purdue Pharma (RAPP) after his son, Eddie, died from an OxyContin overdose in 2001. After Eddie's death, Ed started a website to warn others about the dangers of OxyContin and began connecting with other parents who had lost children to the drug. This led to the formation of RAPP, a group that has been actively protesting and seeking to hold Purdue Pharma and the Sackler family accountable for their role in the opioid crisis. Key details about Ed Bisch and RAPP: Formation: Ed Bisch founded RAPP around 2003 with three other mothers who also lost children to opioids. Anyone who has stood up to Purdue Pharma or spoken out against them is considered a member. Activism: RAPP is known for holding protests and attending hearings, often with photos of their deceased children, to keep pressure on the company and its owners. Ed has also been a claimant in a class-action lawsuit against Purdue Pharma and the Sackler family. Goal: The primary goal of RAPP is for Purdue Pharma and the Sackler family executives to receive jail time for their involvement in the opioid crisis, arguing that financial penalties are not enough of a deterrent. Media Attention: Ed Bisch's activism has been featured in various media, including the MTV series "True Life," the MSNBC special "The Forgotten Epidemic," and articles by authors like Beth Macy ("Dopesick" and "Raising Lazarus"). He has been a consistent voice calling for the Department of Justice to prosecute the Sacklers. Settlement Views: Ed Bisch has been vocal in his criticism of the various settlements reached with the Sackler family, calling them "a bankruptcy scam" and a "sad joke" because the payouts to victims are very small and the Sacklers' fortune remains largely untouched. He also points out that the settlements often include immunity from future civil lawsuits. HELP SUPPORT OUR FIGHT AGAINST ADDICTION. DONATE HERE: https://www.patreon.com/theaddictionpodcast   PART OF THE GOOD NEWS PODCAST NETWORK. AUDIO VERSIONS OF ALL OUR EPISODES: https://theaddictionpodcast.com CONTACT US: The Addiction Podcast - Point of No Return theaddictionpodcast@yahoo.com Intro and Outro music by: Decisions by Kevin MacLeod is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/ Source: http://incompetech.com/music/royalty-free/index.html?isrc=USUAN1100756 Artist: http://incompetech.com/

Multimodal analgesia refers to a pain medication strategy that targets multiple chemical pathways to achieve adequate pain relief. This concept has grown in popularity over the years particularly in light of the recognition that opioids have major downsides including dependence. We welcome Dr. J. Preston Van Buren, DO from the Naval Medical Center in San Diego to discuss his team's findings after implementing a focused multimodal analgesia strategy with a reduced number of prescribed opioid tablets following Sports Medicine surgery compared to a more traditional, opioid-heavy regimen that has been classically employed. 

In this episode of the NCS Podcast Masterclass series, hosts Jon Rosenberg, MD, and Stephan A. Mayer, MD, FCCM, FNCS, are joined by Carolina B. Maciel, MD, MSCR, and Katharina Busl, MD, MS, professors of neurology at the University of Florida. They explore the evolution of opioid-sparing pain management strategies in patients with subarachnoid hemorrhage and acute brain injury. The conversation highlights Dr. Maciel and Dr. Busl's work with sphenopalatine ganglion nerve blocks and the design of a phase 2 clinical trial investigating this novel technique. The guests also discuss the limitations of traditional analgesic options, the complexities of headache mechanisms in neurocritical care and how targeted interventions may improve outcomes and quality of life for patients in the neuro ICU. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

My guest is Dr. Chris McCurdy, PhD, FAAPS, professor of medicinal chemistry at the University of Florida and a world expert on the pharmacology of kratom and other plant-derived medicinal compounds. We discuss kratom's wide-ranging effects, including its use for boosting energy, enhancing mood, managing pain and as a potential opioid substitute, while also explaining its critical safety concerns and addictive potential, especially for kratom-derived/isolate products. We also discuss plant-based compounds more generally for their potential benefits and risks. Dr. McCurdy offers a balanced perspective on kratom and other plant-based and naturally occurring medicinal compounds, highlighting and contrasting their promise for human health with potential serious risks. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman David Protein: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman ROKA: https://roka.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00:00 Chris McCurdy 00:02:51 Kratom (Mitragyna speciosa), Origin, Effects, Low vs High Doses 00:07:19 Sponsors: David Protein & Eight Sleep 00:10:07 Kratom, Traditional Use vs Commercial Kratom Products, Absorption 00:17:00 Kratom Products, Serving Size, Kids; Semi-Synthetics; Tool: Understand Kratom Product Labels 00:23:16 Kratom Products & Various Desired Effects; Physical Dependence 00:32:53 Different Kratom Usage Patterns, Opioid Dependence 00:36:59 Alkaloid Compounds, Nitrogen, Nicotine; Animals & Self-Experimentation 00:47:47 Sponsors: AG1 & ROKA 00:51:05 Medicine Development, Disconnection from Nature, Product Concentrations 00:59:00 Alkaloids & Natural Products, Opium Poppy, Coca Leaf, Tool: Kratom Leaf vs Extracts (Kratom-Derived/Kratom Isolates) 01:09:06 Is It Safe for Kids to Consume Kratom Products? 01:12:19 Kratom, Energy, Mood & Pain Management, Dose; Caffeine 01:16:56 Respiratory Depression & Kratom Products 01:20:16 Sponsor: Function 01:22:04 Kratom Leaf vs Derivatives, FDA Regulations, Usage Guidelines 01:26:59 Kratom, Alcohol Consumption, Respiratory Failure? 01:29:09 Kratom Alkaloids, Mood & Stimulant Effects, Multiple Pathways for Pain Relief 01:38:17 Plant Alkaloids & Chemical Defense, Kratom & Antifungal Alkaloids; Geckos 01:44:35 White, Red & Brown Vein Kratom, Leaf Processing; Terpenes 01:51:08 Kratom as an Anti-Depressant?; Discontinuing Kratom Use, Opioid Use 01:58:03 Kratom, Drug Interactions & Seizure, Opioids 02:01:51 Cacao Beans, Chocolate 02:09:34 Coca-Cola, Coca Plant & Cocaine, History of Soft Drinks 02:19:49 Career Journey, Pharmacy, Chemistry & Education, Lobelia 02:28:44 Nicotine; Natural Products & Career Journey, Salvia divinorum, Kratom 02:40:22 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices